Literature DB >> 33573881

The Dual Roles of Clusterin in Extracellular and Intracellular Proteostasis.

Sandeep Satapathy1, Mark R Wilson2.   

Abstract

Clusterin (CLU) was the first reported secreted mammalian chaperone and impacts on serious diseases associated with inappropriate extracellular protein aggregation. Many studies have described intracellular CLU in locations outside the secretory system and recent work has shown that CLU can be released into the cytosol during cell stress. In this article, we critically evaluate evidence relevant to the proposed origins of cellular CLU found outside the secretory system, and advance the hypothesis that the cytosolic release of CLU induced by stress serves to facilitate the trafficking of misfolded proteins to the proteasome and autophagy for degradation. We also propose future research directions that could help establish CLU as a unique chaperone performing critical and synergic roles in both intracellular and extracellular proteostasis.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  autophagy; chaperone; clusterin; misfolded proteins; neurodegenerative diseases; proteasome; proteostasis

Year:  2021        PMID: 33573881     DOI: 10.1016/j.tibs.2021.01.005

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  9 in total

Review 1.  Clusterin, other extracellular chaperones, and eye disease.

Authors:  Mark R Wilson; Sandeep Satapathy; Shinwu Jeong; M Elizabeth Fini
Journal:  Prog Retin Eye Res       Date:  2021-12-10       Impact factor: 19.704

Review 2.  Exploring the translational potential of clusterin as a biomarker of early osteoarthritis.

Authors:  Ursule Kalvaityte; Csaba Matta; Eiva Bernotiene; Peter Natesan Pushparaj; Ata M Kiapour; Ali Mobasheri
Journal:  J Orthop Translat       Date:  2021-12-10       Impact factor: 5.191

Review 3.  Stress-responsive regulation of extracellular proteostasis.

Authors:  Jaleh S Mesgarzadeh; Joel N Buxbaum; R Luke Wiseman
Journal:  J Cell Biol       Date:  2022-02-22       Impact factor: 10.539

4.  Quantitative Plasma Proteomics to Identify Candidate Biomarkers of Relapse in Pediatric/Adolescent Hodgkin Lymphoma.

Authors:  Ombretta Repetto; Laura Caggiari; Mariangela De Zorzi; Caterina Elia; Lara Mussolin; Salvatore Buffardi; Marta Pillon; Paola Muggeo; Tommaso Casini; Agostino Steffan; Christine Mauz-Körholz; Maurizio Mascarin; Valli De Re
Journal:  Int J Mol Sci       Date:  2022-08-31       Impact factor: 6.208

Review 5.  The Influence of Clusterin Glycosylation Variability on Selected Pathophysiological Processes in the Human Body.

Authors:  Ewa Janiszewska; Agnieszka Kmieciak; Monika Kacperczyk; Aleksandra Witkowska; Ewa Maria Kratz
Journal:  Oxid Med Cell Longev       Date:  2022-08-28       Impact factor: 7.310

6.  Transcriptomes of Clusterin- and S100B-transfected neuronal cells elucidate protective mechanisms against hypoxia and oxidative stress in the hooded seal (Cystophora cristata) brain.

Authors:  Gerrit A Martens; Cornelia Geßner; Carina Osterhof; Thomas Hankeln; Thorsten Burmester
Journal:  BMC Neurosci       Date:  2022-10-15       Impact factor: 3.264

7.  Clusterin and Its Potential Regulatory microRNAs as a Part of Secretome for the Diagnosis of Abnormally Invasive Placenta: Accreta, Increta, and Percreta Cases.

Authors:  Angelika V Timofeeva; Ivan S Fedorov; Mariya M Pirogova; Oksana N Vasilchenko; Vitaliy V Chagovets; Larisa S Ezhova; Tatiana M Zabelina; Roman G Shmakov; Gennadiy T Sukhikh
Journal:  Life (Basel)       Date:  2021-03-24

Review 8.  HDL Accessory Proteins in Parkinson's Disease-Focusing on Clusterin (Apolipoprotein J) in Regard to Its Involvement in Pathology and Diagnostics-A Review.

Authors:  Izabela Berdowska; Małgorzata Matusiewicz; Małgorzata Krzystek-Korpacka
Journal:  Antioxidants (Basel)       Date:  2022-03-09

Review 9.  Altered protein secretion in Batten disease.

Authors:  Robert J Huber
Journal:  Dis Model Mech       Date:  2021-12-06       Impact factor: 5.758

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.